AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Veeva Systems, Inc. Files Suit To Fight Unfair Business Practices That Limit Employee Rights July 17, 2017 Celsion To Host Research And Development (R&D) Day On Thursday, October 12, 2017 October 12, 2017 Why Even Spinraza Can't Save Biogen's Incoming MS Meltdown October 24, 2017
Veeva Systems, Inc. Files Suit To Fight Unfair Business Practices That Limit Employee Rights July 17, 2017